Federal Trade Commission
The Commission plans to conduct a remedy study to update and expand on the divestiture study it conducted in the mid-1990s to: (1) Assess the effectiveness of the Commission's policies and practices regarding remedial orders where the Commission has permitted a merger but required a divestiture or other remedy, and (2) identify the factors that contributed to the Commission successfully or unsuccessfully achieving the remedial goals of the orders. This is the second of two notices required under the Paperwork Reduction Act ("PRA") in which the FTC seeks public comments on its proposed study in connection with Office of Management and Budget ("OMB") review of, and clearance for, the collection of information discussed herein.
Document Headings Document headings vary by document type but may contain the following: the agency or agencies that issued and signed a document the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to the agency docket number / agency internal file number the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details. Federal Trade Commission AGENCY: Federal Trade Commission (“Commission” or “FTC”). ACTION: Notice and request for comment. SUMMARY: The Commission plans to conduct a remedy study to update and expand on the divestiture study it conducted in the mid-1990s to: (1) Assess the effectiveness of the Commission's policies and practices regarding remedial orders where the Commission has permitted a merger but required a divestiture or other remedy, and (2) identify the factors that contributed to the Commission successfully or unsuccessfully achieving the remedial goals of the orders. This is the second of two notices required under the Paperwork Reduction Act (“PRA”) in which the FTC seeks public comments on its proposed study in connection with Office of Management and Budget (“OMB”) review of, and clearance for, the collection of information discussed herein. DATES: Comments must be received on or before July 16, 2015. ADDRESSES: Interested parties may file a comment online or on paper, by following the instructions in the Request for Comment part of the SUPPLEMENTARY INFORMATION section below. Write “Remedy Study, FTC File No. P143100” on your comment. File your comment online at https://ftcpublic.commentworks.com/​ftc/​hsrdivestiturestudypra2 , by following the instructions on the web-based form. If you prefer to file your comment on paper, mail your comment to the following address: Federal Trade Commission…
Citation: 80 FR 34415
